Tower Research Capital (TRC)’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,571
Closed -$20K 5443
2013
Q3
$20K Buy
+1,571
New +$20K ﹤0.01% 2712